4//SEC Filing
Rubin Jonathan 4
Accession 0001628280-25-007165
CIK 0001356576other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:44 PM ET
Size
8.6 KB
Accession
0001628280-25-007165
Insider Transaction Report
Form 4
Rubin Jonathan
SVP, Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2025-02-19+4,500→ 4,500 total→ Common Stock (4,500 underlying) - Award
Employee Stock Option (Right to Buy)
2025-02-19+20,000→ 20,000 totalExercise: $33.52Exp: 2035-02-19→ Common Stock (20,000 underlying)
Holdings
- 6,905
Common Stock
Footnotes (4)
- [F1]Includes an aggregate of 310 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- [F2]The option vests in four equal annual installments beginning on February 19, 2026.
- [F3]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F4]These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001836067
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:44 PM ET
- Size
- 8.6 KB